Latest News

Air Canada (TSX:AC) has begun a limited pilot of an Alternative Dispute Resolution process for passenger compensation claims under Canada’s Airline Passenger Protection Regulations. This move puts customer experience and complaints handling in sharper focus for shareholders. See our latest analysis for Air Canada. The new ADR pilot and recent route additions come as Air Canada's share price trades at CA$18.53, with a 1-year total shareholder return of 31.05% and a 5-year total shareholder...

Mesoblast (ASX:MSB) is back in focus after the US Food and Drug Administration granted investigational new drug clearance for a registrational trial of Ryoncil in Duchenne muscular dystrophy, a high-need pediatric indication. See our latest analysis for Mesoblast. Despite the FDA news and Ryoncil sales updates, recent trading has been choppy, with a 90 day share price return decline of 33.88%, even as the 3 year total shareholder return stands at 119.59%. At A$2.03, recent moves suggest...

Guangdong Investment (SEHK:270) has drawn fresh attention after releasing its full year 2025 results, recommending a higher final dividend, and naming an Acting Chairman on the same day. See our latest analysis for Guangdong Investment. That backdrop of stronger reported earnings, a higher recommended final dividend and a refreshed board structure has coincided with a 21.93% year to date share price return and a 42.60% 1 year total shareholder return, suggesting momentum has been building...

If you are wondering whether Palo Alto Networks' share price reflects its underlying worth, this article breaks down what current numbers can and cannot tell you about value. Recently, the stock closed at US$173.78, with returns of 8.2% over 7 days, 5.3% over 30 days, 0.4% over 1 year, 78.0% over 3 years and 188.8% over 5 years, which may influence how you think about both opportunity and risk. Alongside these moves, investors have been reacting to ongoing news around cybersecurity demand,...

Brookfield Corporation recently entered into a US$1.00 billion margin loan credit facility maturing in April 2028 and lifted its quarterly dividend by 17% to US$0.07 per share, even as private credit market volatility continues. This combination of added financing flexibility and a higher cash return to shareholders highlights management’s willingness to employ leverage while reinforcing income-focused capital allocation. We’ll now examine how Brookfield’s new US$1.00 billion credit facility...

Spire Global (SPIR) has drawn fresh attention after rolling out an expanded agriculture intelligence platform that fuses 40 years of soil moisture data with daily satellite readings, extended forecasts, and AI driven seasonal guidance. See our latest analysis for Spire Global. The latest agriculture platform launch comes after a busy few weeks that included a ten satellite mission supporting projects in quantum sensing, optical inter satellite links, Earth observation, and IoT connectivity,...

DaisekiLtd (TSE:9793) has wrapped up FY 2026 with fourth quarter revenue of ¥17.4b and basic EPS of ¥44.26, rounding out a trailing twelve month EPS of ¥193.03 on revenue of ¥71.8b. Over recent quarters the company has seen revenue move from ¥17.3b with EPS of ¥41.97 in Q4 FY 2025 to a range between ¥17.9b and ¥18.4b with quarterly EPS between ¥44.26 and ¥51.01 in FY 2026. This gives investors a clear view of how both the top line and per share earnings have tracked through the year. With...

Green railcar financing sets the tone for Trinity Industries stock Trinity Industries (TRN) has drawn fresh attention after subsidiaries arranged a $480.8 million secured green railcar note issuance backed by about 15,082 leased railcars, spotlighting the company’s capital markets and ESG focused financing approach. See our latest analysis for Trinity Industries. The green railcar securitization news arrives as Trinity Industries’ share price trades at $33.42, with a 1-day share price return...

Q1 2026 earnings recap and what it means for SALA (TSE:2734) SALA (TSE:2734) opened its 2026 financial year with Q1 revenue of ¥66,243 million and basic EPS of ¥49.64, anchored by net income of ¥3,188 million that feeds into trailing twelve month EPS of ¥104.08. The company’s quarterly revenue moved from ¥65,986 million in Q1 2025 to ¥66,243 million in Q1 2026, while basic EPS shifted from ¥37.01 to ¥49.64 over the same period, alongside trailing twelve month net income of ¥6,683 million on...

NIO (NYSE:NIO) has revealed its ES9 flagship SUV, described as its largest and most advanced vehicle to date. The company is rolling out new smart driving and high end technology features for the ES9 and upcoming models. Onvo, NIO’s sub brand, is shifting from Nvidia chips to in house Shenji smart driving chips, starting with the L90. NIO shares currently trade at $6.38, with the stock up 29.1% over the past month and 24.1% year to date. Over the past year, NYSE:NIO has returned 92.7%,...

Sakata Seed (TSE:1377) has laid out its Q3 2026 scorecard with revenue of ¥24.9 billion and basic EPS of ¥40.36, set against a backdrop of softer profitability over the past year. The company has seen quarterly revenue move between ¥24.1 billion and ¥26.5 billion over the last six reported periods, while basic EPS has ranged from about ¥40 to ¥91. On a trailing twelve month basis, EPS now sits at ¥246.24 with revenue at ¥99.2 billion as margins have come under pressure. See our full analysis...

Wondering if Cushman & Wakefield at around US$13.54 is offering fair value or a potential mispricing opportunity? This article walks through the key signals behind the current price. The stock has returned 8.3% over the last 7 days and 6.0% over the last 30 days. It sits on a 14.5% year to date decline, yet shows a 57.8% return over 1 year and 41.3% over 3 years, with a 19.5% decline over 5 years. Recent attention around Cushman & Wakefield has centered on its role as a major global real...

If you are wondering whether Itron at around US$92.99 is offering good value today, you are not alone in asking what the current share price really reflects. The stock has recently shown a mixed return pattern, with a 2.8% gain over the past week, a 3.3% decline over the past month, and a 1.6% decline year to date, while the 1 year return sits at a 6.6% loss and the 3 year return at 73.8%. Recent coverage around Itron has focused on its role in power grid technology and smart infrastructure...

The U.S.-Iran ceasefire has shifted sentiment for travel related stocks, and Airbnb (ABNB) quickly moved higher as investors weighed lower crude prices, reduced geopolitical risk, and existing expectations for solid earnings and revenue growth. See our latest analysis for Airbnb. At a share price of $131.40, Airbnb has seen a 1-day share price return of 5.15% and a 7-day share price return of 4.96%. Its 1-year total shareholder return of 8.31% contrasts with weaker 3 month share price...

In recent weeks, Arista Networks has drawn attention after several analysts upgraded the stock and highlighted its growing role in AI-focused data center networking, alongside the launch of liquid-cooled, high-density optics modules for large-scale GPU clusters. An interesting angle is how this wave of analyst optimism is rooted not just in AI demand, but in Arista’s push into advanced Ethernet-based optics that could reshape how hyperscalers build and scale their networks. Next, we’ll...

Analyst coverage from Zacks has put fresh attention on DiamondRock Hospitality (DRH), as the firm reiterates a favorable earnings outlook and Buy ranking, highlighting earnings estimate revisions and valuation metrics versus hotel focused REIT peers. See our latest analysis for DiamondRock Hospitality. The latest Zacks commentary comes as DiamondRock Hospitality’s share price sits at US$9.76, with a 90 day share price return of 6.55% and a 1 year total shareholder return of 39.96%. This may...

Cigna Group, NYSE:CI, is reporting steady revenue growth alongside a significant decline in its customer base over the past two years. This combination suggests product and competitive pressures that are starting to reshape how the company earns its revenue. The shift in customer numbers is becoming a key issue for investors tracking Cigna's long term position in health benefits and related services. Cigna Group, NYSE:CI, recently closed at $277.56, with the share price up 3.8% over the...

Meituan (SEHK:3690) is back in focus after its latest earnings release, where higher fourth quarter and full year sales were reported alongside a shift from prior net income to sizeable losses. See our latest analysis for Meituan. The latest results arrived after a mixed run in the stock, with a 7 day share price return of 9.66% and a 30 day share price return of 11.25%. However, the year to date share price return was negative 15.87% and the 1 year total shareholder return was negative...

If you are wondering whether Heineken at around €69.08 is a fair deal or a stretch, this breakdown will help you make sense of what the current share price might be implying. The stock has returned 2.2% over the last 7 days, while the 1 year return sits at a slight decline of 0.3% and the 3 year return shows a larger 26.8% decline, which may shape how you think about both risk and potential upside. Recent coverage has focused on Heineken's position in the global beverages market and how...

Sankyo Tateyama (TSE:5932) has posted its Q3 2026 numbers with revenue of ¥84,213 million and basic EPS of ¥2.33, alongside net income of ¥73 million that contrasts with prior quarterly losses in the trailing figures. Over recent quarters, revenue has ranged between ¥84,043 million and ¥93,713 million while basic EPS has swung from a loss of ¥61.37 to a small profit of ¥0.35 before Q3, giving a picture of a business where the top line has been relatively steady but earnings have been more...

Wondering if American Express at around US$316 per share is still offering value or if the easy gains are behind it? This breakdown is designed to help you weigh that up with a clear focus on price versus fundamentals. The stock has returned 4.9% over the last 7 days and 3.6% over the last 30 days, while the year-to-date return is a 15.1% decline, compared with a 21.8% return over the last year and 105.8% and 128.0% over the last 3 and 5 years respectively. Recent attention on American...

FDA review extension puts spotlight on Travere Therapeutics The latest move in Travere Therapeutics (TVTX) comes after the FDA extended its review of the supplemental New Drug Application for Filspari. The agency set a new April 2026 action date that reshapes the timeline investors are watching. See our latest analysis for Travere Therapeutics. Travere’s share price has reacted quickly to the FDA update, with a recent 9.5% jump and a 10.65% 1 month share price return. However, the year to...

If you are wondering whether RenaissanceRe Holdings at around US$307 per share still offers value, or if most of the upside is already reflected in the price, this article breaks that question down for you. The stock has recent returns of 3.9% over 7 days, 3.5% over 30 days, 12.8% year to date, 29.3% over 1 year, 51.3% over 3 years and 86.3% over 5 years. These figures naturally raise questions about what is already priced in. Recent news coverage has focused on RenaissanceRe Holdings as a...

Citi’s recent cut to its Polaris (PII) price target, tied to higher macro uncertainty, came just as Q1 North America off road retail units were slightly ahead of management’s earlier expectations. See our latest analysis for Polaris. At a share price of $55.38, Polaris has seen a 5.03% 30 day share price return after a sharp 24.76% share price decline over 90 days. The 1 year total shareholder return of 58.81% contrasts with weak 3 and 5 year total shareholder returns. If this kind of reset...